Courtin, Aurélie <br/><br/>
Anti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancer.  [electronic resource] 

 -  PloS one  2013 
 - e67330 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0067330  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacokinetics<br/>Capecitabine<br/>Carcinoma, Pancreatic Ductal--drug therapy<br/>Cell Line, Tumor<br/>Cytidine Deaminase--metabolism<br/>Deoxycytidine--administration & dosage<br/>Disease Models, Animal<br/>Drug Screening Assays, Antitumor<br/>Fluorouracil--administration & dosage<br/>Mice<br/>Mice, Transgenic<br/>Neoplasm Transplantation<br/>Pancreatic Neoplasms--drug therapy<br/>Prodrugs--administration & dosage<br/>Tissue Distribution<br/>Gemcitabine